Neuren Pharmaceuticals Ltd
ASX:NEU

Watchlist Manager
Neuren Pharmaceuticals Ltd Logo
Neuren Pharmaceuticals Ltd
ASX:NEU
Watchlist
Price: 12.2 AUD -0.08% Market Closed
Market Cap: 1.6B AUD
Have any thoughts about
Neuren Pharmaceuticals Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Neuren Pharmaceuticals Ltd

Current Assets 228m
Cash & Short-Term Investments 213.2m
Receivables 14.9m
Non-Current Assets 110k
PP&E 35k
Other Non-Current Assets 75k
Current Liabilities 9m
Accounts Payable 4.5m
Other Current Liabilities 4.5m
Non-Current Liabilities 29k
Other Non-Current Liabilities 29k

Balance Sheet
Neuren Pharmaceuticals Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
8
4
3
2
4
14
24
37
40
17
Cash
8
4
3
2
4
1
0
7
2
17
Cash Equivalents
0
0
0
0
0
13
24
30
38
0
Short-Term Investments
13
12
2
3
20
0
0
0
0
211
Total Receivables
1
0
1
1
1
1
1
1
1
14
Accounts Receivables
1
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
1
1
1
1
1
1
1
0
Other Current Assets
0
0
0
11
2
0
0
2
2
4
Total Current Assets
22
17
6
16
27
14
25
40
43
247
PP&E Net
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
2
0
0
0
0
0
1
Total Assets
22
N/A
17
-24%
6
-63%
18
+189%
27
+48%
14
-46%
25
+73%
40
+61%
43
+8%
248
+473%
Liabilities
Accounts Payable
3
2
1
1
1
0
0
0
0
1
Accrued Liabilities
0
1
1
1
1
0
1
1
1
3
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
1
39
Total Current Liabilities
3
3
2
2
2
1
1
1
2
43
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
Total Liabilities
3
N/A
3
-11%
2
-19%
2
-22%
2
+25%
1
-72%
1
+35%
1
+7%
2
+109%
43
+2 448%
Equity
Common Stock
104
112
113
121
126
126
146
168
168
173
Retained Earnings
74
87
98
94
91
102
111
118
115
43
Other Equity
11
11
11
11
11
11
11
11
11
11
Total Equity
19
N/A
14
-25%
4
-71%
16
+291%
25
+51%
14
-44%
24
+75%
39
+62%
42
+6%
205
+393%
Total Liabilities & Equity
22
N/A
17
-24%
6
-63%
18
+189%
27
+48%
14
-46%
25
+73%
40
+61%
43
+8%
248
+473%
Shares Outstanding
Common Shares Outstanding
81
88
92
102
103
100
115
126
123
127

See Also

Discover More